DexCom, Inc.
DXCM
$84.67
-$0.67-0.79%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.96% | 12.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.96% | 12.00% | |||
| Cost of Revenue | -2.34% | 14.31% | |||
| Gross Profit | -10.19% | 10.44% | |||
| SG&A Expenses | -5.28% | 6.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.41% | 9.78% | |||
| Operating Income | -29.22% | 24.28% | |||
| Income Before Tax | -26.98% | 19.11% | |||
| Income Tax Expenses | -17.95% | 39.25% | |||
| Earnings from Continuing Operations | -30.52% | 12.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.52% | 12.70% | |||
| EBIT | -29.22% | 24.28% | |||
| EBITDA | -21.48% | 19.01% | |||
| EPS Basic | -30.61% | 13.73% | |||
| Normalized Basic EPS | -27.06% | 20.19% | |||
| EPS Diluted | -30.03% | 13.34% | |||
| Normalized Diluted EPS | -27.10% | 20.13% | |||
| Average Basic Shares Outstanding | 0.13% | -0.91% | |||
| Average Diluted Shares Outstanding | 0.20% | -0.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||